Revolutionary drug for schizophrenia wins US approval

Elie Dolgin

Nature, 2024, vol. 634, issue 8033, 276-277

Abstract: The medication is the first in decades to have a different mode of action from those of current drugs, achieving better symptom relief with fewer side effects.

Keywords: Drug discovery; Medical research; Psychiatric disorders; Schizophrenia (search for similar items in EconPapers)
Date: 2024
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.nature.com/articles/d41586-024-03123-9 Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:nature:v:634:y:2024:i:8033:d:10.1038_d41586-024-03123-9

Ordering information: This journal article can be ordered from
https://www.nature.com/

DOI: 10.1038/d41586-024-03123-9

Access Statistics for this article

Nature is currently edited by Magdalena Skipper

More articles in Nature from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().